Arie Belldegrun

Fund Advisor at VV Manager LLC

Arie Belldegrun

Arie Belldegrun

Fund Advisor at VV Manager LLC

Overview
Career Highlights

Allogene Therapeutics, Inc.
Two River Group Holdings LLC
Equinor ASA

RelSci Relationships

4453

Number of Boards

30

Birthday

1950

Age

69

Number of Awards

1

Contact Data
Trying to get in touch with Arie Belldegrun? Subscribe today to access their professional contact information and receive a one time promotion of free Contact Data credits!
Relationships
RelSci Relationships are individuals Arie Belldegrun likely has professional access to. A relationship does not necessarily indicate a personal connection.

Co-Founder at Kirax Corporation

Relationship likelihood: Strong

Fund Advisor at VV Manager LLC

Relationship likelihood: Strong

Fund Advisor at VV Manager LLC

Relationship likelihood: Strong

Professor & Director, Mimg at University of California - Los Angeles

Relationship likelihood: Strong

Co-Founder at TPG Capital, LP

Relationship likelihood: Strong

Founder at Bellco Capital LLC

Relationship likelihood: Strong

Chairman & President at Riverbank Capital Securities, Inc.

Relationship likelihood: Strong

Co-Founder & Managing Partner at Pontifax Management Co. Ltd.

Relationship likelihood: Strong

Scientific Founder at Cell Design Labs, Inc.

Relationship likelihood: Strong

Venture Partner & Senior Advisor at Pappas Capital LLC

Relationship likelihood: Strong

Paths to Arie Belldegrun
Potential Connections via
Relationship Science
You
Arie Belldegrun
Fund Advisor at VV Manager LLC
Family Members
Spouse
Founder at Bellco Capital LLC

Bellco Capital LLC provides investment advisory services. The company was founded by Rebecka Belldegrun in 2003 and is headquartered in Los Angeles, CA.

Memberships
Fellow
Current

The primary exempt purpose is to improve the quality of care of the surgical patient through education and research.

Career History
Executive Chairman
2017 - Current

Allogene Therapeutics, Inc. operates as a clinical stage immuno-oncology company pioneering the development and commercialization of genetically engineered allogeneic T cell therapies for the treatment of cancer. The firm develops a pipeline of off-the-shelf T cell product candidates that are designed to target and kill cancer cells. Its engineered T cells are allogeneic, which are derived from healthy donors for intended use in any patient. The company was founded by Arie S. Belldegrun, David D. Chang, and Joshua A. Kazam on November 2017 and is headquartered in South San Francisco, CA.

Fund Advisor
2017 - Current
Founder
2009 - Current

Kite Pharma, Inc. engages in the development and commercialization of novel cancer immunotherapy products. It offers chimeric antigen receptor (CAR) and T cell receptor (TCR) product candidates to address both hematological and solid cancers. The company was founded by Arie S. Belldegrun, James S. Economou, and Joshua A. Kazam in June 2009 and is headquartered in Santa Monica, CA.

Non-Profit Donations & Grants

Learn how non-profit organizations benefit from RelSci
$10K - $25K
2015

Survivors of the Shoah visual history foundation is the institute for visual history and education.

$500 - $999
2013

P.S. ARTS' mission is to improve the lives of children by providing arts education to underserved public schools and communities.

$10K +
2011

Survivors of the Shoah visual history foundation is the institute for visual history and education.

Political Donations
$2,500
2012

Senator from South Carolina

$2,300
2007

Former Senator from New York

$25K
2004

The Republican National Committee (RNC) is a U.S. political committee that provides national leadership for the Republican Party of the United States. It is responsible for developing and promoting the Republican political platform, as well as coordinating fundraising and election strategy. It is also responsible for organizing and running the Republican National Convention. Similar committees exist in every U.S. state and most U.S. counties, although in some states party organization is structured by congressional district, allied campaign organizations being governed by a national committee. Reince Priebus is the current RNC Chairman.

Transactions
Details Hidden

Vida Ventures LLC raised money in a private placement transaction

Details Hidden

Kite Pharma, Inc. raised money in a private placement transaction

Investments
Details Hidden

Kronos Bio, Inc. engages in research and development of first-in-class therapies that modulate historically recalcitrant cancer targets. The company was founded by Angela Koehler in 2017 and is headquartered in Cambridge, MA.

Details Hidden

Agensys, Inc. develops a pipeline of therapeutic fully human monoclonal atibodies (mAbs) to treat cancer. It develops a pipeline of naked and antibody-drug conjugated (ADC) therapeutic antibodies to treat cancer indications, including prostate, kidney, pancreas, ovary, bladder, lung, colon, breast, and skin. The company was founded in 1997 and is headquartered in Santa Monica, CA.

Public Holdings
Restricted data only for RelSci Professional users.
Awards & Honors
American Board of Urology - Board Certification in Pediatric Urology
Events
Speaker
Los Angeles, CA, United States
2013 Milken Institute Global Conference

Through a unique international agenda and some of the smartest speakers on the planet, the Milken Institute Global Conference tackles the world’s most difficult challenges in an array of fields - from finance and philanthropy, to the environment and education, to government and health.

This web site is not endorsed by, directly affiliated with, maintained, authorized, or sponsored by Arie Belldegrun. The use of any trade name or trademark is for identification and reference purposes only and does not imply any association with the trademark holder. The Presence of Arie Belldegrun's profile does not indicate a business or promotional relationship of any kind between RelSci and Arie Belldegrun.